The U.S. stock market is now approaching the end of what is typically the most volatile period of a presidential election ...

BTIG analyst Carl Reichardt raised the firm’s price target on PulteGroup (PHM) to $156 from $139 and keeps a Buy rating on the shares.

Competitors are playing catch-up, BTIG noted, with some signs of market share loss in the specialty running segment over the ...

The October 22 report on Hoka noted signs that the running footwear brand’s multi-year growth is moderating. The firm also ...

Fintel reports that on October 17, 2024, BTIG initiated coverage of InMode (NasdaqGS:INMD) with a Buy recommendation. Analyst ...

BTIG downgraded Deckers Outdoor (DECK) to Neutral from Buy without a price target The firm sees the stock’s risk/reward as balanced ...

Fintel reports that on October 17, 2024, BTIG initiated coverage of AirSculpt Technologies (NasdaqGM:AIRS) with a Neutral ...

On Monday, BTIG reiterated a Neutral rating on Ally Financial (NYSE: NYSE:ALLY) shares, citing challenges in the near term regarding the company's credit trends and net interest margins.

“Slowly, then suddenly,” stock investors have been noticing the moves in the bond market, along with the rally for the U.S.

BTIG Research reissued their buy rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Friday morning, Marketbeat.com reports. BTIG Research currently has ...

On Friday, BioNano Genomics Inc (BNGO) stock saw a modest uptick, ending the day at $0.33 which represents no change from the prior close of of $0.33. The stock opened at $0.33 and touched a low of $0 ...